Navigation Links
EUROPLASMA: Résultats consolidés 2012
Date:9/26/2013

BORDEAUX, France, September 26, 2013 /PRNewswire/ --



Le Conseil d'Administration d'Europlasma, réuni le 18 septembre 2013 sous la présidence de Pierre Catlin, a arrêté les comptes sociaux et les comptes consolidés de l'exercice clos au 31 décembre 2012. Il a été décidé de réunir les actionnaires en Assemblée Générale Mixte le 8 novembre 2013, à Bordeaux.

Les diligences d'audit sur les comptes sociaux et consolidés sont en cours de finalisation par le collège des commissaires aux comptes.

Activité et résultats

En milliers d'euros (KEUR) 2012 2011 Variation Chiffre d'affaires 35 338 58 030 -22 692 -39% EBITDA -9 204 2 688 -11 892 -442% Résultat opérationnel - 18 215 -446 -17 769 - 3 984% Résultat financier -4 327 -345 -3 982 - 1 154% Résultat net de la période -21 152 -1 235 -19 917 - 1 613% Résultat net, part du Groupe -20 891 -1 341 -19 550 - 1 458% Résultat par action (en euros par action) -1,33 -0,09 -1,24 - 1 378%

Source  : Comptes consolidés 2012 arrêtés par le Conseil d'Administration du 18/09/2013

Activité et chiffre d'affaires

Le chiffre d'affaires consolidé annuel 2012 s'établit à 35 338 K€, soit une baisse de 39% par rapport à 2011, concentrée au niveau des secteurs d'activité Energies Renouvelables et Air et Gaz.

L'activité « Etude et Ingénierie, torches et procédés » a enregistré un chiffre d'affaires de 2 457 K€ en 2012, ce qui représente 7% de l'activité du Groupe contre 2% en 2011.

Depuis 2010, Europlasma collabore avec Iberdrola et Belgoprocess dans
'/>"/>

SOURCE Europlasma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 Why ... that makes Albert Einstein so instantly recognizable? Why have ... physicist, mathematician, astronomer and author Hilton Ratcliffe seeks out ... have nothing at all to do with science. In ... Harbor Publishing , November 21, 2014), Ratcliffe puts it ...
(Date:11/21/2014)... - Aequus Pharmaceuticals Inc. (the "Company" or "Aequus") ... a brokered private placement offering (the "Brokered Offering") ... Securities Inc. and Clarus Securities Inc. acted as ... syndicate of agents that also included Wolverton Securities ... Concurrently with the Brokered Offering, the Company also ...
(Date:11/18/2014)... FL (PRWEB) November 17, 2014 ... point-of-care diagnostic tests – today announces its third ... and Prevention’s (CDC) Get Smart About Antibiotics Week ... Week is a national campaign designed to highlight ... health departments, and non-profit and for-profit partners to ...
(Date:11/18/2014)... New Brunswick, NJ (PRWEB) November 18, 2014 ... of Data Quality and Transparency Reporting solutions, announced ... has gone live using its Consummate Provider™ solution ... Consummate Provider™ is a Global, SaaS based, Data ... Science organizations and their third party Providers improve ...
Breaking Biology Technology:“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 2RPS Again Partners with the CDC in Support of the 2014 Get Smart About Antibiotics Week 3Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2
... Viruses can wreak havoc on bacteria as well as humans ... in place, explains Professor John van der Oost, at the ... the bacterial "immune system" could be used to keep industrial ... his team at Wageningen University in the Netherlands have spent ...
... ... statistically significant pain relief at five minutes post-dose using electronic patient diary data ... PITTSBURGH, PA (Vocus) ... outcomes (PRO) solutions and services for global clinical research, today announced that its ...
... immune system senses and tracks down infection in the body ... immune cells manipulate their movement in response to external signals ... functions but also how cancer cells spread through the body ... the Society for General Microbiology,s spring meeting in Edinburgh, Dr ...
Cached Biology Technology:invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial 2invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial 3How immune cells 'sniff out' bacteria 2
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)... , November 4, 2014   ... market growth   Fuel3D , a developer ... a funding round totaling $6.4 million (£4 million). This funding ... secured earlier this year and paves the way for the ... The funding round was led by Chimera Partners ...
(Date:11/3/2014)... ANGELES , Nov. 3, 2014  NeuroSigma ... -based life sciences company focused on commercialization ... system for the treatment of neurological and ... of Industrial Property has issued a Notice of ... patent application is co-owned by NeuroSigma and the ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... Researchers at Brigham and Women,s Hospital (BWH) have demonstrated ... human platelet function and causes a peak in platelet ... cardiovascular events. These findings are published in PLoS ... disease is still the number one cause of death ...
... article (DOI: 10.1603/IPM10024) in the Journal of Integrated ... species of thrips present in U.S. cotton, their plant host ... biology, and management practices currently available to growers. ... in the United States and constitute one of the most ...
... DC (Sept 9, 2011) -- The blood levels of ... patients will develop heart problems, need dialysis, and die ... issue of the Journal of the American Society ... which patients need early treatment, thereby lowering their health ...
Cached Biology News:Body clock found to regulate platelet function 2Hormone predicts which kidney patients might die early 2